Guided Therapeutics, Inc.’ LuViva® Advanced Cervical Scan Detected 100% Of Precancers In New Blinded Clinical Study Presented At An International Cervical Pathology And Colposcopy Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The LuViva® Advanced Cervical Scan identified 100% of all cervical disease cases in a blinded clinical study presented at the International Federation for Cervical Pathology and Colposcopy (IFCPC) meeting in London on May 27, 2014. LuViva also correctly identified 44% of women who had a previous abnormal Pap test and who were determined to be false positives as part of the study.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC